BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 8752441)

  • 1. [A view for understanding the pathogenesis of multiple sclerosis].
    Tabira T
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1493-5. PubMed ID: 8752441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
    Madsen LS; Andersson EC; Jansson L; krogsgaard M; Andersen CB; Engberg J; Strominger JL; Svejgaard A; Hjorth JP; Holmdahl R; Wucherpfennig KW; Fugger L
    Nat Genet; 1999 Nov; 23(3):343-7. PubMed ID: 10610182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein.
    Elliott EA; McFarland HI; Nye SH; Cofiell R; Wilson TM; Wilkins JA; Squinto SP; Matis LA; Mueller JP
    J Clin Invest; 1996 Oct; 98(7):1602-12. PubMed ID: 8833909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that Fas and FasL contribute to the pathogenesis of experimental autoimmune encephalomyelitis.
    Dittel BN
    Arch Immunol Ther Exp (Warsz); 2000; 48(5):381-8. PubMed ID: 11140465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler's virus-induced demyelinating disease.
    Fuller KG; Olson JK; Howard LM; Croxford JL; Miller SD
    Methods Mol Med; 2004; 102():339-61. PubMed ID: 15286394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initiation and regulation of CNS autoimmunity.
    Goverman J; Brabb T; Paez A; Harrington C; von Dassow P
    Crit Rev Immunol; 1997; 17(5-6):469-80. PubMed ID: 9419434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of MHC class II expressing CD4+ T cells in proteolipid protein(91-110)-induced EAE in HLA-DR3 transgenic mice.
    Mangalam A; Rodriguez M; David C
    Eur J Immunol; 2006 Dec; 36(12):3356-70. PubMed ID: 17125142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system.
    Yan SS; Wu ZY; Zhang HP; Furtado G; Chen X; Yan SF; Schmidt AM; Brown C; Stern A; LaFaille J; Chess L; Stern DM; Jiang H
    Nat Med; 2003 Mar; 9(3):287-93. PubMed ID: 12598893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of T cell epitopes on human proteolipid protein and induction of experimental autoimmune encephalomyelitis in HLA class II-transgenic mice.
    Mangalam AK; Khare M; Krco C; Rodriguez M; David C
    Eur J Immunol; 2004 Jan; 34(1):280-90. PubMed ID: 14971054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presentation of proteolipid protein epitopes and B7-1-dependent activation of encephalitogenic T cells by IFN-gamma-activated SJL/J astrocytes.
    Tan L; Gordon KB; Mueller JP; Matis LA; Miller SD
    J Immunol; 1998 May; 160(9):4271-9. PubMed ID: 9574529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunopathogenesis of multiple sclerosis.
    Wekerle H
    Acta Neurol (Napoli); 1991 Apr; 13(2):197-204. PubMed ID: 1891986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local delivery of cytokines by retrovirally transduced antigen-specific TCR+ hybridoma cells in experimental autoimmune encephalomyelitis.
    Dal Canto RA; Costa G; Shaw MD; Seroogy C; Nolan GP; Fathman CG
    Eur Cytokine Netw; 1998 Sep; 9(3 Suppl):83-91. PubMed ID: 9831193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of experimental autoimmune encephalomyelitis in Lewis rats by a viral peptide with limited homology to myelin basic protein.
    Mao YS; Lu CZ; Wang X; Xiao BG
    Exp Neurol; 2007 Aug; 206(2):231-9. PubMed ID: 17617406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triggers of autoimmune disease in a murine TCR-transgenic model for multiple sclerosis.
    Brabb T; Goldrath AW; von Dassow P; Paez A; Liggitt HD; Goverman J
    J Immunol; 1997 Jul; 159(1):497-507. PubMed ID: 9200491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental autoimmune encephalomyelitis mediated by CD8+ T cells.
    Ji Q; Goverman J
    Ann N Y Acad Sci; 2007 Apr; 1103():157-66. PubMed ID: 17376824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innate and adaptive immune requirements for induction of autoimmune demyelinating disease by molecular mimicry.
    Olson JK; Ludovic Croxford J; Miller SD
    Mol Immunol; 2004 Feb; 40(14-15):1103-8. PubMed ID: 15036915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD28 costimulation is crucial for the development of spontaneous autoimmune encephalomyelitis.
    Oliveira-dos-Santos AJ; Ho A; Tada Y; Lafaille JJ; Tonegawa S; Mak TW; Penninger JM
    J Immunol; 1999 Apr; 162(8):4490-5. PubMed ID: 10201986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microglial cell activation and proliferation precedes the onset of CNS autoimmunity.
    Ponomarev ED; Shriver LP; Maresz K; Dittel BN
    J Neurosci Res; 2005 Aug; 81(3):374-89. PubMed ID: 15959904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myelin oligodendrocyte glycoprotein-35-55 peptide induces severe chronic experimental autoimmune encephalomyelitis in HLA-DR2-transgenic mice.
    Rich C; Link JM; Zamora A; Jacobsen H; Meza-Romero R; Offner H; Jones R; Burrows GG; Fugger L; Vandenbark AA
    Eur J Immunol; 2004 May; 34(5):1251-61. PubMed ID: 15114658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis.
    Garay L; Gonzalez Deniselle MC; Gierman L; Meyer M; Lima A; Roig P; De Nicola AF
    Neuroimmunomodulation; 2008; 15(1):76-83. PubMed ID: 18667803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.